Summary:
The purpose of this study is to determine if the study medication given, in addition to your current medication Aricept(Donezepil), Razadyne (Galantamine) or Rivastigmine (Exelon) can improve memory, thinking, reasoning in patients with Alzheimer's disease (dementia).
Qualified Participants Must:
• Be 50 years of age, or older
•
Have a probable diagnosis of Alzheimer's who has been treated with Aricept, Razadyne or Exelon and is on a stable dose for the previous 4 months
•
Have a "caregiver" who can attend all 7 visits, this person should be in contact with the subject frequently and be able to report on the subject's activity, ability to do things independently, etc
Qualified Participants May Receive:
If you qualify and sign an informed consent form for a study, you may receive reimbursement for travel and inconvenience for every visit you complete.